Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy

Sir,

We read with great interest the recent meta-analysis by Chung et al,¹ which reached important conclusions about the effect of intravitral bevacizumab in central serous chorioretinopathy; nevertheless, some methodological issues need to be addressed concerning this meta-analysis.¹

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD